ExLibris header image
SFX Logo
Title: Prediction of Nonlinear Intestinal Absorption of CYP3A4 and P-Glycoprotein Substrates from their In Vitro Km Values
Source:

Pharmaceutical Research [0724-8741] Tachibana, Tatsuhiko yr:2011


Collapse list of basic services Basic
Full text
Full text available via SpringerLINK Contemporary 1997-Present
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Kim, Richard B. "Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein." Pharmaceutical Research 16.3 (1999): 408-14. Link to Full Text for this item Link to SFX for this item
2. Sjostedt, N. "Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier." Pharmaceutical research 31.1 (2014): 1-19. Link to Full Text for this item Link to SFX for this item
3. Ito, K. "Database analyses for the prediction of in vivo drug-drug interactions from in vitro data." British journal of clinical pharmacology 57.4 (2004): 473-86. Link to Full Text for this item Link to SFX for this item
4. Yang, Gary M. "Effect of prototypical inducing agents on P-glycoprotein and CYP3A expression in mouse tissues." Drug metabolism and disposition (2004): 1008-14. Link to SFX for this item
5. Houston, J. n. "Progress Towards Prediction of Human Pharmacokinetic Parameters from In Vitro Technologies." Drug metabolism reviews 35.4 (2003): 393-415. Link to SFX for this item
6. Bian Sheng, Juan i. "In vitro and in vivo study of dolichyl phosphate on the efflux activity of P-glycoprotein at the blood-brain barrier." International journal of developmental neuroscience 31.8 (2013): 828-835. Link to SFX for this item
7. Sadiq, Muhammad W. "Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship." Journal of pharmaceutical sciences 102.9 (2013): 3320-3331. Link to Full Text for this item Link to SFX for this item
8. Lim, Diane C. "Obstructive sleep apnea and cognitive impairment: Addressing the blood–brain barrier." Sleep medicine reviews 18.1 (2013): 35-48. Link to SFX for this item
9. Ball, K. "Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone." Journal of pharmaceutical sciences 101.11 (2012): 4277-92. Link to Full Text for this item Link to SFX for this item
10. Wang, Wang J. "HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein." Pharmaceutical research 18.6 (2001): 800-806. Link to Full Text for this item Link to SFX for this item
11. Benet, L Z Z. "Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery." Journal of controlled release 62.1-2: 25-31. Link to SFX for this item
12. Welling P G, P G G. "Effects of food on drug absorption." Annual review of nutrition 16.1 (1996): 383-415. Link to Full Text for this item Link to SFX for this item
13. McLeod, M. "The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem." Molecular Brain Research 104.2 (2002): 203-. Link to Full Text for this item Link to SFX for this item
14. Ioannides, C. "Cytochromes P450 in the bioactivation of chemicals." Current topics in medicinal chemistry 4.16 (2004): 1767-88. Link to SFX for this item
15. Edginton, Andrea N. "Have physiologically-based pharmacokinetic models delivered?" Expert Opinion on Drug Metabolism and Toxicology 7.8 (2011): 929-934. Link to SFX for this item
16. Klaassen, X. "Regulation of mRNA expression of xenobiotic transporters by the pregnane x receptor in mouse liver, kidney, and intestine." Drug metabolism and disposition 34.11 (2006): 1863-7. Link to SFX for this item
17. Khan, A. "Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver." European journal of pharmaceutical sciences 37.2 (2009): 115-125. Link to SFX for this item
18. Srinivas, Nuggehally R R. "Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil." European journal of clinical pharmacology 64.11 (2008): 1135-6. Link to Full Text for this item Link to SFX for this item
19. Clement, E W. "Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4." Chemical research in toxicology 14.12 (2002): 1596-603. Link to Full Text for this item Link to SFX for this item
20. Wierzbicki, AS S. "The lipid and non-lipid effects of statins." Pharmacology & therapeutics 99.1 (2003): 95-112. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.